. Phase I and phase II of short-term mechanical restitution in perfused rat left ventricles. Am J Physiol Heart Circ Physiol 282: H1311-H1319, 2002. First published December 6, 2001 10.1152/ajpheart.00464.2001.-We examined the contributions of the Ca 2ϩ channels of the sarcolemma and of the sarcoplasmic reticulum to electromechanical restitution. Extrasystoles (F 1) were interpolated 40-600 ms following a steady-state beat (F 0) in perfused rat ventricles paced at 2 or 3 Hz. Plots of F 1/F0 versus the extrasystolic interval consisted of phase I, which occurred before relaxation of the steady-state beat, and phase II, which occurred later. Phase I exhibited a period of enhanced left ventricular pressure development that coincided with action potential prolongation. Phase I was eliminated by ϪBAY K 8644 (100 nM) and FPL 64176 (150 nM), augmented by 3 M thapsigargin plus 200 nM ryanodine and unaffected by KN-93 and KB-R7943. Phase II was accelerated by the Ca 2ϩ channel agonists and by isoproterenol but was eliminated by thapsigargin plus ryanodine. The results suggest that phase I of electromechanical restitution is caused by a transient L-type Ca 2ϩ current facilitation, whereas phase II represents the recovery of the ability of the sarcoplasmic reticulum to release Ca 2ϩ .
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L-type calcium channels; sarcoplasmic reticulum; ryanodine receptors; myocardium; calmodulin MECHANICAL RESTITUTION is the time-dependent recovery of the ability of the heart to contract following the previous beat. That is, a premature stimulus or extrasystole introduced soon after the relaxation of a steadystate beat produces an attenuated twitch, the amplitude of which depends on the duration of the extrasystolic interval (ESI) (36) . As the interval between the relaxation of a steady-state beat and the extrasystole is increased, there is an exponential increase in the amplitude of the extrasystolic beat. In fact, as the interval is prolonged beyond that of the basic cycle length, the twitch amplitude continues to increase and becomes greater than that of the steadystate beat before reaching a plateau (36) . In 1975, Bass (3) termed this monoexponential recovery of force or pressure development phase II of mechanical restitution. He noted that when extrasystoles are interpolated very early and before relaxation of the steady-state beat, there is a period of enhanced relative force development (phase I) that is accompanied by action potential prolongation (4) . The phase I enhancement of force development declines with increasing extrasystolic intervals, reaching a minimum value or reversal point (3). This reversal point can be taken as the boundary between phase I and phase II, but there undoubtedly is functional overlap, with the process(es) responsible for phase II possibly beginning near the extrapolated value for T 0 . Mechanical restitution and other aspects of the myocardial strength-interval relation (1, 24, 33) may reflect 1) changes in the gating mode of the L-type Ca 2ϩ channels (dihydropyridine receptors, DHPRs) (29, 33) ; 2) changes in the extent to which Ca 2ϩ release channels (ryanodine receptors, RyRs) of the sarcoplasmic reticulum (SR) recover the ability to release Ca 2ϩ (34) ; 3) alterations in the amount of Ca 2ϩ contained in the SR (6) ; and 4) cross-talk between the RyRs and the DHPRs wherein Ca 2ϩ influx via the L-type Ca 2ϩ channels triggers SR Ca 2ϩ release and Ca 2ϩ released from the SR inactivates the DHPRs (6) . Each of these processes appears to be highly regulated and offers a potential target for therapeutic modalities designed to improve electromechanical function in diseased hearts.
The present study examined mechanical restitution in perfused rat left ventricles subjected to a variety of pharmacological perturbations. The biphasic nature of the mechanical restitution curves was abrogated by Ca 2ϩ channel agonists, whereas phase II was eliminated by thapsigargin plus ryanodine. The results suggest that phase I of electromechanical restitution is dominated by changes in L-type Ca 2ϩ currents, whereas phase II reflects recovery of the ability of the SR to release Ca 2ϩ . We also observed that phase II of mechanical restitution is markedly accelerated by agents that are thought to increase the Ca 2ϩ content of the SR.
MATERIALS AND METHODS

Isolated Langendorff Perfused Hearts
Hearts from young (300-400 g) male Sprague-Dawley rats purchased from Zivic Miller (Portersville, PA) or Harlan (Indianapolis, IN) were used in this study. All animals were maintained on a 12:12-h light-dark cycle in a fully accredited facility. For in vitro studies of left ventricular performance, rats were injected intraperitoneally with 155 mg pentobarbital sodium per kg body wt. An abdominal incision was made, and heparin (0.7 mg) was injected into the inferior vena cava. The thorax was opened, and hearts were rapidly excised and placed in ice-cold modified Krebs-Henseleit buffer containing (in mM) 109 NaCl, 5 KCl, 1.2 MgSO4, 1 CaCl2, 25 HEPES, 13 NaOH, 10 glucose, 10 sodium pyruvate, 0.1 EDTA, and insulin (84.9 USP units/l buffer). Hearts were cannulated via the aorta and, for most experiments, perfused retrograde in a nonrecirculating Langendorff mode at 20 ml/min with modified Krebs-Henseleit buffer, pH 7.4, saturated with 100% O2. In experiments involving scarce or costly pharmacological agents, 200-400 ml of drug-containing buffer were recirculated. Temperature was maintained at 32°C.
After a 10-to 15-min equilibration period, the atria were removed, and the atrioventricular node was crushed. This slowed the intrinsic heart rate to about 120 beats/min. Hearts were immersed in a 10-ml beaker bath containing outflow perfusate to prevent drying and to facilitate temperature control. Hearts were paced at a basic cycle length of either 333 or 500 ms using platinum electrodes, one of which was connected to the metal cannula and the other immersed in the beaker bath. Voltage was set at 5 V. A water-filled latex balloon connected via polyethylene tubing to a pressure transducer (Viggo-Spectramed) was inserted into the left ventricle, and the end-diastolic pressure was adjusted to 8 mmHg. Steady-state left ventricular developed pressure (LVDP) was typically between 120 and 150 mmHg. An IBM-XT fitted with a CIO-DACO2 card (Computerboards; Mansfield, OH) and run using a LabView virtual instrument acted as the stimulator. Data were acquired at a rate of 200 points/s.
Action Potential Measurements
To measure action potentials in whole Langendorff perfused rat hearts, we used high temporal and spatial resolution fluorescence imaging of electrical activity as described earlier (12) . Briefly, hearts were stained by a bolus injection of di-4-ANEPPS (Molecular Probes; Eugene, OR) with the final concentration not exceeding 20 M. Data acquisition was begun 5-15 min following the staining. The dye was excited by light from a 250-W DC-powered tungsten halogen light source (Oriel). Excitation was controlled by an electronic shutter (Oriel), which opened for only a few seconds during each scan. Excitation light was passed through an infrared filter (KG1, Schott Glass) and a 520 Ϯ 45 nm interference filter (Omega Optical) and was deflected by a 585-nm dichroic mirror (Omega Optical) into an image lens, which then focused the excitation light onto the heart. The emitted fluorescence was collected by a 50-mm lens (1:1.4, AF Nikkor, Nikon), passed through a cutoff filter (Ͼ610 nm, Schott), and focused on the sensing area of a 16 ϫ 16 photodiode array (Hamamatsu C4675). Sampling was performed at a rate of 1,894 frames/s, and each frame included 256 optical channels and 8 instrumentation channels. Data were digitally acquired and stored on a hard disk for off-line analysis.
The core of the optical mapping system is a 16 ϫ 16 photodiode array (PDA) detector that combines a 16 ϫ 16 element PDA with 256 current-to-voltage converters (feedback resistor of 10 m⍀, resulting in a gain of 10 7 V/A) in a single compact (136 ϫ 136 ϫ 154) enclosure. The PDA records from a large enough surface area of the preparation to receive enough photons per unit time for an accurate representation of an optical action potential. Subtraction of background fluorescence is done on a per-channel basis. The photocurrent produced by each photodiode is first stage amplified and converted to voltage by its own low-noise operational amplifier. Increasing the first stage amplification has been reported to improve signal-to-noise ratios in optical signals (14) . The outputs of the first stage amplifiers are connected to 256-s stage amplifiers, which are reset immediately before data acquisition, to remove the DC offset of the optical signals caused by background fluorescence. Signals are filtered by Bessel filters and fed to a multiplexer and an analog-todigital converter board (Microstar Laboratories).
The spectroscopic properties of styryl dyes (RH-421, di-4-ANEPPS, and di-8-ANEPPS) have been shown to change linearly with membrane potential changes in the normal physiological range of transmembrane voltages in the axon (31) and heart (32) . The precise depth of optical recordings in preparations stained by perfusion has been subject to debate. Model calculations by Salama (32) , based on the depth of field of the optical system, predicted a depth of 144 m. Measurements by Knisley et al. (23) in a tapering wedge of tissue showed that the intensity of optical action potentials ceased to increase if the thickness of the tissue was Ͼ300 M. From the measurements of the absorption coefficient of myocardium for the excitation and emission spectrum, Girouard et al. (15) predicted that 95% of the signal originates from a tissue depth of 500 M or less.
A major limitation of current techniques of potential imaging is the lack of absolute calibration. Unlike many ratio-metric fluorescent probes for calcium imaging, voltage-sensitive dyes can provide only relative information about changes in transmembrane voltage. Although the changes in the absolute amount of fluorescence excited at one wavelength linearly depends on transmembrane voltage of the viewed cells, accurate calibration has so far been impossible because the number of cells contributing to the signal is unknown.
To measure action potential (AP) amplitudes and areas at 50% repolarization, we chose to average fluorescence signals that originated from the surface of the central part of the left ventricle, where motion artifacts are minimal. For each ESI, we averaged signals coming from at least four adjacent photodiodes facing the central region of the epicardium. We measured AP amplitudes, and we calculated by integration the area under the AP from the origin of the upstroke up to the point corresponding to 50% repolarization. Because of the lack of absolute calibration, both areas under AP and AP amplitudes are normalized to the F0 areas or amplitudes.
Most studies of electrical activity and mechanical restitution were done separately because the presence of an intraventricular balloon increased movement artifacts in the fluorescence traces. Agents such as butane dione monoxime (2) or cytochalasin D (38) that directly interfere with force development were not used in any of these studies. Instead, only those fluorescence traces showing a clear absence of movement artifacts, usually from the central region of the preparation, were analyzed.
Experimental Design
Pacing protocols. After a priming period of 100 beats at 3 Hz, test beats (extrasystoles) were introduced at varying time intervals, from as early as 40 ms to as late as 600 ms. Beyond 600 ms the hearts generally exhibited spontaneous activity. In experiments where high concentrations of thapsigargin and ryanodine were employed to disable the SR, the pacing rate was reduced to 2 Hz to allow for more complete relaxation of the steady-state beats. All extrasystoles were followed by an immediate return to the basic cycle length. That is, when the steady-state pacing frequency was 3 Hz, there was a standard 333-ms interval between the extrasystolic and the first postextrasystolic stimulus. Likewise, when the steady-state pacing rate was 2 Hz, there was a standard 500-ms interval between the extrasystolic and first postextrasystolic stimulus. Each pacing protocol was repeated two to three times for each heart, and the F 1/F0 data were averaged to obtain a single set of values for each heart. The average standard error for triplicate F1/F0 values was ϳ2% of the F1/F0 ratio.
Reagents. ϪBAY K 8644 and ryanodine were purchased from Calbiochem (LaJolla, CA). KB-R7943 (KBR) was the generous gift of Kanebo Pharmaceutical Laboratories (Osaka, Japan). All other reagents were purchased from Sigma (St. Louis, MO).
Data Analysis
Extrasystoles partially fused with control contractions were separated using a program for graphical analysis (Origin), by subtracting from the fused contraction the control contraction just preceding it (Fig. 1) . The maximum developed pressure of the resultant derived extrasystolic contraction was measured (F 1), and restitution curves were drawn by plotting the percentage of mechanical restitution, F 1/F0 ϫ 100%, where F 0 is the steady-state value of LVDP against the ESI. A similar computerized subtraction method was used to separate overlapping APs, and the extrasystole amplitude F 1 was divided by the amplitude of the steady-state AP F0. F1/F0 values were again plotted as a function of ESI. Similar calculations were done using areas under the APs at 50% repolarization.
Phase II of mechanical restitution was curve fit using Origin software and the equation
where X is the ESI, T0 is the X-axis intercept, and B ϭ /ln 2, where is the time constant for mechanical restitution. The values for the reversal point (nadir) and the data point immediately following it (e.g., ESIs of 230 and 250 ms in Fig. 2) were not used in the curve fitting because of the apparent overlap with phase I.
Comparisons between complete restitution curves (phase I plus phase II) were done using Origin software and a resident statistical package for repeated measures one-way analysis of variance (ANOVA). When the complete curves were significantly different from each other we used a Newman-Keuls post hoc test to determine which time points were significantly different between the two curves. We also used oneway ANOVA to determine which F 1/F0 values were significantly different from 100%. A P value Ͻ0.05 was considered to be statistically significant. 
RESULTS
Mechanical Restitution
Figure 2 summarizes restitution data for a group of untreated normal hearts. Note the early increase in F 1 /F 0 , which peaked at an ESI of ϳ150 ms and thereafter declined, reaching the nadir or reversal point at ϳ230 ms. This phase I reached its peak value 30 ms after the steady-state beat developed maximum pressure, and the reversal point occurred before complete relaxation of the control beat, when about 35% of LVDP still persisted. Phase II of mechanical restitution was characterized by an exponential increase in F 1 /F 0 with a of 98 Ϯ 8 ms, T 0 of 196 Ϯ 4 ms, and Y max of 158 Ϯ 4%. Also shown in Fig. 2 are data for the first beat following the extrasystole, i.e., the postextrasystolic beat, F 2 . None of these postextrasystoles were fused to an adjacent beat, so the data are simple ratios of the directly measured LVDPs of the F 2 and F 0 beats. Phase I of mechanical restitution paralleled changes in AP area at 50% repolarization (Fig. 3) , which is related to the strength and duration of the L-type Ca 2ϩ current (33); there were no significant time-dependent changes in APs coinciding with phase II of mechanical restitution. Figure 4 illustrates the effects of isoproterenol and the Ca 2ϩ channel agonists ϪBAY K 8644 and FPL-64176 on mechanical restitution. Effects of these compounds on steady-state left ventricular contractile performance are summarized in Table 1 Fig. 5 ). KN-93 had no significant effect on steady-state contractile parameters (n ϭ 6). KBR, a putative inhibitor of the Na ϩ /Ca 2ϩ exchanger (21), slightly reduced the amplitude of the early phase I ratios, but the effect failed to reach statistical significance (Fig. 6) . KBR had no statistically significant effects on steady-state LVDP or time to peak pressure (n ϭ 4), but there was a significant To assess the involvement of the SR in phase I of mechanical restitution, hearts were perfused with thapsigargin, a specific inhibitor of the SR Ca 2ϩ pump (22) , plus ryanodine, a compound that renders the SR leaky to Ca 2ϩ (17) . This reduced peak systolic left ventricular pressure (LVP) to 88 Ϯ 22 mmHg, increased end-diastolic pressure to 48 Ϯ 14 mmHg, decreased ϩdP/dt max to 410 mmHg/s, and decreased ϪdP/ dt max to 235 Ϯ 62 mmHg/s (n ϭ 3). Figure 7 is a typical pressure recording. Note the greatly enhanced relative amplitude of the extrasystole at 170 ms (basic cycle length, 500 ms) and the absence of postextrasystolic potentiation. Figure 8 summarizes the mechanical restitution data for a group of hearts perfused with thapsigargin plus ryanodine. With the SR unable to participate in excitation-contraction coupling, phase I of mechanical restitution was greatly exaggerated, whereas phase II was nearly flat. KN-93 (3 M) had no statistically significant effect on mechanical restitution in the presence of thapsigargin plus ryanodine (Fig. 8) .
DISCUSSION
The present study demonstrates that the electromechanical restitution of perfused rat left ventricles consists of two distinct phases: phase I, which is completed before the full relaxation of the steady-state beats, and phase II, which occurs later. Aside from the classic 1975 papers by Bass (3, 4), which described the two phases of electromechanical restitution in cat papillary muscles, most investigations have focused on phase II, specifically on that portion of phase II that follows complete relaxation of the steady-state beat (1, 36, 40) . In such studies, there typically are mathematical extrapolations to zero developed force or zero intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) transient amplitude as the ESI is shortened; fused waveforms are not dealt with (36) . Phase II appears to be a monoexponential process that results from the recovery of the ability of the RyRs of the SR to release calcium (34, 36) . This may result from the recovery of the RyRs from inactivation (34) or adaptation (16) . There could also be a time-dependent refilling of highly localized SR Ca 2ϩ stores (8) .
The characterization of phase I of mechanical restitution at first appears to be problematic in that it requires the computerized subtraction of a steady-state Values are means Ϯ SE; n, numbers of rats. LVDP, left ventricular developed pressure; dP/dtmax, maximal rates of pressure.
beat to separate out the amplitude and configuration of very premature extrasystoles. This raises questions about whether force development, APs, and Ca 2ϩ transients can realistically be thought of as additive for fused responses that result from two closely spaced stimuli. The curve describing the relative strength of the first postextrasystolic beat at short ESIs, which is similar in shape to the F 1 /F 0 curve, suggests that the computerized subtractions do provide realistic data. Extra calcium entering the cell in response to a premature stimulus is thought to be taken up by the SR, becoming available for release during the subsequent beat (5, 28) . When the premature stimulus occurs while the RyRs are refractory, the extra contractile response of the postextrasystolic beat to this extra Ca 2ϩ is roughly proportional to the amount of Ca 2ϩ entering the cell during the extrasystole. Thus the time course and magnitude of changes in F 1 /F 0 as a function of the ESI for both the extrasystoles and the associated first postextrasystolic beats (F 2 /F 0 ) were similar during phase I. Moreover, rat ventricular APs, because of their brief duration, are less fused than the corresponding mechanical traces at short ESIs, and their AP areas at 50% repolarization also paralleled the computerresolved LVDPs for early extrasystoles. The present study demonstrated that phase I of electromechanical restitution is independent of SR Ca 2ϩ release and can be observed when the SR is chemically disabled with thapsigargin plus ryanodine and is unable to accumulate or retain significant amounts of Ca 2ϩ . Phase II, on the other hand, appears to be almost entirely attributable to recovery of the SR Ca 2ϩ release process because this phase is flat when the SR can no longer accumulate or retain Ca 2ϩ . Interestingly, neither phase was significantly affected by the putative cardiac Na ϩ /Ca 2ϩ exchange inhibitor KBR (19, 25) . We used 10 M KBR because of a reported IC 50 of 1.2-2.4 M for reverse mode Na ϩ / Ca 2ϩ exchange inhibition. Concentrations higher than 10 M might have significantly affected other ion channels (19) , which would have confounded interpretation of the data. Ladilov et al. (25) found 20 M KBR to be the maximally effective dose in studies of perfused rat hearts and isolated adult rat cardiomyocytes, but significant inhibition was obtained with 10 M KBR. Because there was a trend toward a decrease in the maximum F 1 /F 0 ratios during phase I in hearts perfused with 10 M KBR, a portion of the increase in F 1 /F 0 during phase I in the absence of drug could have been due to Ca 2ϩ influx via reverse mode Na ϩ /Ca 2ϩ exchange. Phase I of mechanical restitution was markedly exaggerated by perfusion with thapsigargin plus ryanodine, which were used to limit respectively SR Ca Janczewski and Lakatta (20) A study of mechanical restitution in ferret papillary muscles failed to detect an overshoot in Ca 2ϩ -dependent aequorin luminescence for early fused beats in the presence of ryanodine (36), as might have been predicted by our data. Unfortunately, in that study, fused mechanical responses were not resolved, leaving it unclear whether such muscles exhibited an exaggerated mechanical phase I. It is also unclear whether ryanodine alone is as effective as ryanodine plus thapsigargin in eliminating the contribution of the SR to excitation-contraction coupling. The present study did not examine the effects of ryanodine alone on electromechanical restitution.
It should be emphasized that the exaggeration of phase I of mechanical restitution in the presence of thapsigargin and ryanodine was associated with a ϳ70% reduction in steady-state LVDP. LVDP averaged only 40 mmHg compared with ϳ130 mmHg for control steady-state beats. Because the peak F 1 /F 0 shown in Fig. 8 is 190% , it follows that the mean peak F 1 amplitude is only ϳ75 mmHg, or about half that of typical control steady-state beats at 3 Hz. Nevertheless, perfusion with thapsigargin plus ryanodine allowed a near doubling of LVDP for very early extrasystoles, over and above that which could be attributed to the absence of L-type Ca 2ϩ current inactivation by SR Ca 2ϩ release (6) and the lack of SR sequestration of Ca 2ϩ entering through the L-type Ca 2ϩ channels (20) . It has been estimated that L-type Ca 2ϩ current can double when Ca-dependent current inactivation by Ca 2ϩ released from the SR is eliminated (6) . Our data suggest that a further doubling of Ca 2ϩ influx is possible for very premature beats in the intact rat heart and emphasize the importance of Ca 2ϩ -dependent Ltype Ca 2ϩ current inactivation and facilitation as mechanisms for grading cardiac contractility.
As shown in the companion paper (9), electromechanical restitution kinetics are altered significantly in failing spontaneously hypertensive, heart failure (SHHF-Mccfa cp ) rat hearts. We therefore initiated a series of experiments to characterize factors that might regulate either phase I or phase II of mechanical restitution in normal rat hearts and thus possibly explain the differences in restitution kinetics accompanying heart failure. Phase II could be accelerated dramatically by positive inotropic agents such as the ␤-adrenergic agonist isoproterenol, and by the dihydropyridine Ca 2ϩ channel agonist ϪBAY K 8644 and the nondihydropyridine Ca 2ϩ channel agonist FPL-64176. All three of these compounds would be predicted to increase the amount of Ca 2ϩ contained in the SR due to the increase in L-type Ca 2ϩ current. Isoproterenol should have the additional effect of causing phosphorylation of phospholamban, the endogenous inhibitor of the SR Ca-ATPase (7) . In vivo studies of mechanical restitution in transgenic mice with varying amounts of myocardial phospholamban (18) indicated that restitution was fastest in phospholamban knockout mice, intermediate in wild-type mice, and slowest in mice overexpressing phospholamban in the heart. These mouse data lend support to the concept that SR Ca 2ϩ content is a major determinant of the rate of phase II mechanical restitution.
The acceleration of phase II of mechanical restitution by isoproterenol and the Ca 2ϩ channel agonists was retarded slightly by the CaM kinase II inhibitor, KN-93. Thus CaM kinase-dependent phosphorylation of RyR2 (37) or an accessory protein (27) may have contributed somewhat to the acceleration of phase II of mechanical restitution. However, the pronounced increase in SR Ca 2ϩ load caused by these positive inotropic agents was probably responsible for most of the acceleration of mechanical restitution (6) . All three drugs induced spontaneously reversible periods of visibly disorganized contractile behavior and zero LVDP at the initiation of pacing. This behavior was suggestive of ventricular fibrillation, which is commonly associated with an SR Ca 2ϩ overload (6, 26) . Under conditions where ␤-adrenoceptor stimulation does not increase the SR Ca 2ϩ load, it has been reported that there is no effect of ␤-agonists on the recovery of the ability of cardiac RyRs to release Ca 2ϩ (35) . Isoproterenol had little effect on phase I of mechanical restitution, except to abbreviate it, owing for the most part to a greater overlap with the accelerated phase II and a shift of the reversal point from 230 to 150 ms. The two chemically distinct Ca 2ϩ channel agonists, on the other hand, abrogated the reversal point separating phase I and phase II. This would be explained if the Ca 2ϩ channel agonists elicited maximum activation of the L-type Ca 2ϩ channels and if the rise in F 1 /F 0 during phase I with Ca 2ϩ channel agonists absent were due to transient voltage and/or Ca 2ϩ -dependent L-type Ca 2ϩ channel facilitation coupled with the time-dependent recovery of electrical excitability. Facilitation involves an increase in the type II L-type Ca 2ϩ channel gating mode that is characterized by very prolonged openings (29) . Ca 2ϩ channel agonists also act to increase type II openings (13) . The subsequent decline in F 1 /F 0 in the absence of the Ca 2ϩ channel agonists could then be due to the time-dependent decay of facilitation, which would not occur with the Ca 2ϩ channel agonists present. Isoproterenol also increases type II openings (29) , but increases in SR Ca 2ϩ uptake as a consequence of phospholamban phos-phorylation (11) account for a large fraction of the resulting positive inotropic effect. As shown in Table 1 , the maximally effective dose of isoproterenol (1 M) had much larger effects on ϮdP/dt max than did the Ca 2ϩ channel agonists, suggesting a more pronounced effect on the kinetics of SR Ca 2ϩ accumulation and possibly a lesser effect on the L-type Ca 2ϩ channels. Surprisingly, phase I of mechanical restitution was not affected by CaM kinase inhibition with KN-93, despite good evidence that Ca 2ϩ current facilitation in single cardiomyocytes results from CaM kinase activation (10, 39) . It should be noted that the concentration of KN-93 used in the experiments summarized in Fig.  8 (3 M) was threefold higher than that used for the experiments summarized in Fig. 5 , where a small but statistically significant effect of KN-93 was observed. Thus we should have seen an effect of KN-93 on phase I of mechanical restitution in the presence of thapsigargin plus ryanodine if CaM kinase II were responsible for the observed increase in F 1 /F 0 at short ESIs. That we did not raises the possibility that cardiac Ca 2ϩ current facilitation is not a single process in the intact heart but is instead several processes that together regulate frequency-dependent changes in Ca 2ϩ influx across the sarcolemma. The changes observed in the present study peaked at ϳ150 ms at a slightly hypothermic temperature of 32°C and relatively slow pacing frequencies for rat hearts of 2-3 Hz. Most evidence for CaM kinase-dependent Ca 2ϩ channel facilitation has dealt with longer time scales, as might be more appropriate for a phosphorylation-dependent mechanism.
Both Ca 2ϩ -dependent facilitation and inactivation of L-type Ca 2ϩ channels require the presence of calmodulin bound to an isoleucine glutamine (IQ) motif in the carboxy tail of the ␣ 1 -subunit (41) . Replacement of the native isoleucine of the IQ domain with alanine removes Ca 2ϩ -dependent channel inactivation and unmasks a strong facilitation, whereas conversion of the isoleucine to glutamate eliminates both facilitation and inactivation (41) . A peptide representing another region in the carboxy-terminal sequence of the L-type Ca 2ϩ channel, the CB peptide, binds Ca 2ϩ CaM and enhances Ca 2ϩ -dependent Ca 2ϩ current (I Ca ) facilitation when injected into cardiac myocytes, again suggesting a direct effect of Ca 2ϩ CaM on this process (30) .
Limitations of the Present Study
In the present study, there were no direct measurements of [Ca 2ϩ ] i , L-type Ca 2ϩ current density, or SR Ca 2ϩ content or release. It was therefore necessary to interpret the results in light of published data on more carefully controlled systems and to employ pharmacological maneuvers in an attempt to address mechanistic issues. On the other hand, intact multicellular preparations are stable and can be subjected to conditions that more closely resemble the in vivo situation in terms of stimulation frequency, temperature, and intracellular environment (33) . Moreover, the perfusion of intact ventricles reduces concerns about core ischemia in thick trabeculae or papillary muscles. No isolated system can replicate the in vivo heart, however, and the entire range of systems from single channel recordings to unanesthetized animals must be investigated to complete our understanding of the critically important cardiac force-interval relation and its changes with cardiac pathology.
